WAVEMAN · COMPANY

FTK · Flotek Industries Inc/Cn/

LIVE

TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475

← ALL COMPANIES

FTK

Name: FLOTEK INDUSTRIES INC/CN/ (FTK) insider trading and ownership data
Creator: WaveMan
License: https://wave-man.com/terms

FLOTEK INDUSTRIES INC/CN/

PHARMA & BIOTECH · MISCELLANEOUS CHEMICAL PRODUCTS · CIK 0000928054

SEC FILINGS☆ WATCH

INSIDER NET · 180D

-$252.1K

open-market buys minus sells, Form 4 codes P and S

INSIDER BUYERS · 180D

CONGRESS BUYERS · 1Y

FUNDS ADDED · QTR

13F, latest reported quarter

REVENUE GROWTH

+26.9%

XBRL, annual

NET MARGIN

12.9%

SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST

INSIDERS

net -$252.1K over 180 days

below 51% of Pharma & Biotech

CONGRESS

no member of Congress has reported trading it

FUNDS

67 funds added or opened last quarter

more than 52% of Pharma & Biotech

REVENUE

+26.9% year over year

more than 73% of Pharma & Biotech

MARGIN

12.9% net margin

more than 83% of Pharma & Biotech

BUYBACKS

no share repurchases reported

SHORT

7.8% of shares outstanding short · 8.5 days to cover · settled 2026-07-31

more than 68% of Pharma & Biotech

THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET

67 funds added or opened positions in the latest 13F quarter, of 115 holders.

The year, with the filings on it

Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail

TOTAL 12M RETURN +97.3%

+97.3%12M

INSIDER SELL

INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY

Live price

Daily candles from TradingView, on their licence — no filings are marked on this one

WHY THIS NAME IS ON THE DESK

The complete filing record, in one place.

The record shows a net $252.1K sold by insiders over 180 days, 67 funds added last quarter. Every figure is a federal filing, dated the day it became public.

Backtest this pattern Open the screener

Same sector, ranked by filing activity

Sector from the SEC's own SIC classification

UTHR CPIX MRNA REGN LLY ALNY ELF CITR MDGL DNA VRTX NUVL

Insider transactions

Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, FLOTEK INDUSTRIES INC/CN/ insiders sold a net $252.1K of stock across 70 Form 4 purchases and sales, with 0 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-05.

INSIDER

FILED

VALUE

CLEMENT JAMES BOND

Chief Financial Officer

SELL

2026-05-18

12,554.0

$252.1K

CLEMENT JAMES BOND

Chief Financial Officer

SELL

2026-02-24

6,299.0

$100.9K

Agadi Harshavardhan V

Director

SELL

2025-11-13

66,956.0

$984.9K

Ezell Ryan Gillis

Chief Executive Officer

SELL

2025-08-14

87,187.0

$1.1M

CLEMENT JAMES BOND

Chief Financial Officer

SELL

2025-08-13

45,732.0

$582.6K

70 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 65 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders

13F · holdings as of the latest quarter funds have reported

Driehaus Capital Management LLC

1,136,326.0 sh

$26.7M

ROYCE & ASSOCIATES LP

1,105,132.0 sh

$26.0M

MASTERS CAPITAL MANAGEMENT LLC

1,000,000.0 sh

$23.5M

BlackRock, Inc.

856,775.0 sh

$20.2M

DIMENSIONAL FUND ADVISORS LP

704,371.0 sh

$16.6M

SCHEDULE 13D/G

No 5%+ ownership filings

Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.

FORM 144

No planned-sale notices

No insider has notified an intent to sell. This is the panel to watch after a run-up.

Fund concentration

N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show

Royce Smaller-Companies Growth Fund

$4.3M POSITION · AS OF 2026-03-31

2.4%

Nuveen Small Cap Value Opportunities Fund

$4.0M POSITION · AS OF 2026-03-31

1.5%

Buffalo Early Stage Growth Fund

$871.9K POSITION · AS OF 2026-03-31

1.4%

Even Herd Long Short ETF

$698.0K POSITION · AS OF 2026-03-31

1.2%

Driehaus Micro Cap Growth Fund

$2.6M POSITION · AS OF 2026-03-31

0.6%

Needham Small Cap Growth Fund

$678.8K POSITION · AS OF 2026-03-31

0.4%

SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK

Fundamentals

Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all

	2025-12	2024-12	2023-12	2022-12
REVENUE	$237.3M	$187.0M	$188.1M	$136.1M
GROSS PROFIT	$59.8M	$39.4M	$24.3M	$-6.7M
OPERATING INCOME	$23.2M	$12.2M	$23.2M	$-35.4M
NET INCOME	$30.5M	$10.5M	$24.7M	$-42.3M
EPS (DILUTED)	0.84	0.34	-0.10	-3.41
OPERATING CASH FLOW	$7.2M	$3.4M	$-11.3M	$-44.6M
CASH	$5.7M	$4.4M	$5.9M	$12.3M
LONG-TERM DEBT	$40.0M	$0	$60.0K	$2.7M

SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-05 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE